Proteome Sciences (PRM) Stock Chart & Stock Price History GBX 2.78 -0.26 (-8.55%) As of 08:37 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock Proteome Sciences Stock Price Performance The Proteome Sciences (PRM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 10.61%, with a year-to-date return of -25.07%. In the past month, the stock has decreased 13.48%, reflecting recent market activity. As of the latest close, Proteome Sciences traded at GBX 3.36 with a market cap of £9.92 million and volume of 34,498 shares. Five years ago, the stock traded at GBX 4.51, representing a 38.36% decrease over that period. At the time, it had a market cap of £13.31 million and a volume of 165,081 shares. Receive PRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-15.24%1 Month Performance-13.48%3 Month Performance+2.21%Year-To-Date Performance-25.07%1 Year Performance-10.61%5 Year Performance-38.36% PRM Stock Chart for Wednesday, August, 6, 2025 PRM Chart by TradingView Proteome Sciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025GBX 3.36GBX 2.78-17.26%GBX 2.78GBX 2.7816,577 shs£8.21 million08/05/2025GBX 3.48GBX 3.36-3.45%GBX 3.36GBX 2.6034,498 shs£9.92 million08/04/2025GBX 3.28GBX 3.48+6.10%GBX 3.48GBX 2.7877,133 shs£10.27 million08/01/2025GBX 3.28GBX 3.28GBX 3.28GBX 2.7387,000 shs£9.68 million07/31/2025GBX 3.28GBX 3.28GBX 3.28GBX 3.282,684 shs£9.68 million07/30/2025GBX 2.68GBX 3.28+22.48%GBX 3.28GBX 3.282,684 shs£9.68 million07/29/2025GBX 3.04GBX 2.68-11.91%GBX 2.68GBX 2.6894 shs£7.91 million07/28/2025GBX 3.04GBX 3.04GBX 3.48GBX 2.6314,580 shs£8.97 million07/25/2025GBX 2.63GBX 2.63GBX 3.48GBX 2.63265,308 shs£7.75 million07/24/2025GBX 3.01GBX 2.63-12.65%GBX 3.48GBX 2.63265,308 shs£7.75 million Get the Latest News and Ratings for PRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025GBX 3.32GBX 3.01-9.49%GBX 3.39GBX 3311,804 shs£8.87 million07/22/2025GBX 2.61GBX 3.32+27.25%GBX 3.32GBX 3.3230,645 shs£9.80 million07/21/2025GBX 2.61GBX 2.61GBX 2.61GBX 2.61265,301 shs£7.70 million07/18/2025GBX 2.76GBX 2.61-5.40%GBX 2.61GBX 2.61265,301 shs£7.70 million07/17/2025GBX 2.83GBX 2.76-2.37%GBX 2.83GBX 2.76282,000 shs£8.14 million07/16/2025GBX 2.83GBX 2.83GBX 2.83GBX 2.8315,976 shs£8.34 million07/15/2025GBX 3.39GBX 2.83-16.72%GBX 2.83GBX 2.831,162 shs£8.34 million07/14/2025GBX 3.39GBX 3.39GBX 3.48GBX 3.22700,846 shs£10.01 million07/11/2025GBX 2.65GBX 3.39+27.86%GBX 3.48GBX 3.22700,846 shs£10.01 million07/10/2025GBX 3.04GBX 2.65-12.73%GBX 2.65GBX 2.6570,815 shs£7.83 million07/09/2025GBX 3.03GBX 3.04+0.33%GBX 3.04GBX 3.0446,005 shs£8.97 million07/08/2025GBX 3.03GBX 3.03GBX 3.21GBX 2.6122,189 shs£8.94 million Related Companies Polar Capital Technology Trust Stock Chart James Latham Stock Chart Seeing Machines Stock Chart Mobile Streams Stock Chart ANGLE Stock Chart Abingdon Health Stock Chart genedrive Stock Chart GENinCode Stock Chart Verici Dx Stock Chart LungLife AI Stock Chart Receive PRM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Proteome Sciences and its competitors with MarketBeat's FREE daily newsletter. This page (LON:PRM) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredInstant Cash (every 3rd Monday)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteome Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.